Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology

Abstract

Background Access to essential medicines is a universal human right and availability and affordability are the preconditions for it. In line with the sustainable development goals, World Health Organization (WHO) has outlined a framework that assists the policy makers to improve access to essential medicines for universal health coverage by 2030. However, the availability and affordability of essential medicines remains suboptimal in several low-income countries. Therefore, this study was designed to investigate the availability, pricing and affordability of essential medicines in eastern Ethiopia. Methods A cross-sectional study design was employed to conduct this study. Public and private health facilities found in Eastern Ethiopia and which fulfilled criteria set forth by WHO/Health Action International (HAI) guideline and essential medicines listed on WHO/HAI guideline and essential medicine list of Ethiopia were included. Accordingly, 60 medicine outlets were selected based on the WHO/HAI standardized sampling methodology. A standardized data collection tools developed by WHO/HAI, with necessary modifications, was employed to collect the data. Median Price Ratio (MPR) was computed as a ratio of median local buyers’ price to international buyers’ reference price. The Mann–Whitney U test was employed to compare the median buyers’ price between public and private health facilities. Kruskal–Wallis test was also run to explore the median price difference among all facilities. Treatment affordability was calculated based on the number of days of wage of the lowest-paid government employee of Ethiopia required to purchase the prescribed regimen. Results The overall percent availability of originator brand (OB) versions of essential medicines was found to be 3.6% (range: 0.0–31.7%), with the public and private sectors contributing 1.43% and 5.50%, respectively. The overall percent availability of lowest price generics (LPGs) was 46.97% (range: 1.7–93.3%) (Public: 42.5%; private: 50.8%). Only eight LPGs (16.0%) met the WHO target of 80%. The Mann–Whitney U test indicated that 64% drugs showed statistically significant median price difference between public and private settings (p < 0.05). The MPR value indicated that the median buyers’ price of drugs in private sector were more than four times the international reference price in 30% of drugs. The percentage of unaffordable medicine were 72.09 and 91.84% for public and private facilities, respectively, with 79.17% of the medicines were unaffordable when both settings were combined. Conclusion Only 16% of the surveyed medicines surpassed the WHO cut-off point of 80%. Nearly one-third of drugs in the private sector had a price of more than four times compared to the international reference prices. Moreover, four out of five drugs were found unaffordable when both settings were combined, demanded several days of wage of lowest paid government employee. This finding calls a prompt action from stakeholders to devise a strategy that help promote the access of essential medicines and rescue the struggling healthcare system of Ethiopia.

Cancer signs and risk factors awareness in Addis Ababa, Ethiopia: a population-based survey

“…Ethiopia's national cancer control plan also called for cancer awareness programs to be integrated into the daily routines of health education provided at all public healthcare facilities in the country [17]. Medication and transportation to the country's public healthcare facilities, on the other hand, are too expensive, which may have discouraged the elderly from seeking medical help or visiting the healthcare facilities and benefiting from the awareness program provided there [49][50][51]. This is primarily because the majority of Ethiopia's elderly do not have a steady source of income or adequate pensions [52,53].…”

Availability, price, and affordability of medicines used for the management of Covid-19 in health facilities of Dessie town WHO/HAI survey

“…A systematic review conducted in Ethiopia reported that the average availability of essential medicine in public and private health facilities was 70.16% and 70.1%, respectively [ 27 ]. In Eastern Ethiopia, the overall availability of LPG was 46.97% (public 42.5% and private 50.8%) [ 28 ]. Another study also reported low availability [ 29 ].…”

“…However, the Mann-Whitney test showed that there was no statistically significant price difference among health facilities. Findings in Ethiopia revealed that the MPR of the private sector was more than four times higher than the international purchasing price in 30% of drugs [ 28 ]. Higher pharmaceutical price was found in the United States market [ 35 , 36 ].…”

“…The price difference between the public and private sectors was also apparent in China [ 31 ]. A statistically significant price difference was reported between the private and public sectors in Ethiopia [ 28 ] and China [ 31 ]. However, non-significant price variation was also reported in China [ 30 ].…”

Availability and stock-out duration of essential medicines in Shegaw Motta general hospital and Motta Health Centre, North West Ethiopia

“…Besides, Medicine availability in Ethiopia is hindered by a lack of transportation infrastructure and long distances from suppliers, especially in rural areas where medicines are sometimes transported by humans [14][15][16][17]. The lack of resources or information can create barriers to accessing essential medicines in many developing countries, contributing to higher rates of death and illness [18].…”